Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 07 Oct 2026 for Arbutus Biopharma Corp, €79k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Robert A. Beardsley: trading record in brief
Filings by Robert A. Beardsley span 2 companies, the busiest being Arbutus Biopharma Corp and Galera Therapeutics, Inc. We count 8 filings; the first trade dates from 12 November 2019 and the latest from 1 October 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 7 October 2026, reports a transaction of €79k in Arbutus Biopharma Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert A. Beardsley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
17,948 shares@ US$5.00Common SharesSEC:0001447028-26-000061:0
78,800 shares@ US$4.240.034% mcap33.3% of flowCommon SharesSEC:0001447028-26-000050:1
52,533 shares@ US$3.200.017% mcap16.7% of flowCommon SharesSEC:0001447028-26-000050:0
99,057 shares@ US$5.070.052% mcap50.0% of flowCommon SharesSEC:0001447028-26-000050:2
10,000 shares@ US$1.0726.0% of flowCommon StockSEC:0000899243-22-036697:0
10,000 shares@ US$1.0726.5% of flowCommon StockSEC:0000899243-22-030911:0
20,000 shares@ US$1.0747.4% of flowCommon StockSEC:0000899243-21-049011:0
7 of 7 declarations
